Logo - International Journal of Pharmaceutical Compounding

Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement

Author(s):  Milner Martin

Issue:  Jul/Aug 2005 - Human Hormone Replacement Therapy
View All Articles in Issue

Abstract:  Hypothyroidism is a common condition. A large percentage of patients remain significantly symptomatic in spite of apparently adequate replacement therapy. Symptoms may include intractable chronic fatigue, impaired concentration, and weight gain. These symptoms may have devastating consequences on quality of life. Changing medication to a blend of T4 with slow-release T3 resolves many of these limitations on patients’ quality of life. The compounding of exact customized levels of T4 and T3 enables the clinician to achieve optimal targeted serum levels of thyroid-stimulating hormone, free T4, and free T3 with precision. These levels can be carefully customized to optimize symptom resolution while improving metabolic temperature status. Customized compounding allows dose adjustments to achieve whatever balance of T4 and T3 is necessary to achieve optimal health and resolution of symptoms.

Related Keywords: Martin Milner, ND, hypothyroidism, thyroid disorders, thyroid hormone replacement, T3 and T4 balance, customized therapy, individualized therapy

Related Categories: SUPPORT, CASE REPORTS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=2213

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products